Experiment 927405
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | JOHNSON,DH: GRECO,FA: STRUPP,J: HANDE,KR: HAINSWORTH,JD:. (1990). PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL-CELL LUNG CANCER: A PHASE II TRIAL.. 8(10) |
| Amount utilized | |
| Compound isolated | |
| Disease | 22 PATIENTS WERE USED IN THIS PHASE II TRIAL. THERE WERE 2 COMPLETE AND 8 PARTIAL REMISSIONS. THE PREDOMINANT TOXICITY WAS MYELOSUPPRESSION. DOSAGE WAS GIVEN DAILY. |
| Dose amount | 50.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |